Our bilayered self-assembled skin substitutes (SASS) are skin substitutes showing a structure and functionality very similar to native human skin. These constructs are used, in life threatening burn wounds, as permanent autologous grafts for the treatment of such affected patients even though their production is exacting. We thus intended to shorten their current production time to improve their clinical applicability. A self-assembled decellularized dermal matrix was used. It allowed the production of an autologous skin substitute from patient's cells. The characterization of SASS reconstructed using a decellularized dermal matrix (SASS-DM) was performed by histology, immunofluorescence, transmission electron microscopy and uniaxial tensile analysis.
3

Introduction
In recent years, the treatment of severely burned patients has been improved by the use of living skin substitutes produced by tissue engineering. 1 Skin substitutes have the ability to deliver cytokines, chemokines, growth factors and competent cells at wound site, thus improving the wound closure. 2, 3 Definitive treatment of extensive burns requires that autologous skin be used since other allogenic grafts are rejected after several days/weeks. In a context of the production of engineered living skin substitutes, the use of the patient's own cells oversteps immune incompatibility problems but requires that the production of such skin constructs be initiated only after isolating patient's cells.
Our group previously presented a bilayered self-assembled skin substitute (SASS) made of a dermal substitute underlying a fully differentiated epidermis, which generated an engineered tissue similar in structure and function to native human skin [4] [5] [6] for clinical use in wound healing 7 and burn treatment. 8, 9 SASS is currently used in a clinical trial for the permanent coverage of full-thickness wounds (ClinicalTrials.gov NCT02350205).
The self-assembly strategy used to produce a reconstructed dermal substitute entails that adult or neo-natal fibroblasts, cultured under adequate conditions, produce and organize their own extracellular matrix without exogenous scaffold. [10] [11] [12] [13] With our current standard protocol, the production of the dermal substitute of the SASS requires 3-4 weeks and is the most time consuming step. 12, 14 Our aim was to modify the SASS production process to obtain a significant reduction in the dermal production time from the point where the patient's cells have been harvested and expanded in culture, allowing quicker grafting of the skin substitute on the patient. The chosen approach was to use of a self-assembled pre-produced acellular dermal matrix for autologous cell seeding. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Some available dermal matrices use xenogenic material (bovine collagen, chondoitin-6-sulfate, polyglactin, polyglycolide (PGA), etc) that can eventually stimulate untoward immunologic response in some patients. 15, 16 The extracellular matrix (ECM) of the acellular dermal matrix presented herein is produced from the cells themselves, thus generating substitutes with an ECM composition quite similar to native tissue. [4] [5] [6] Cells are then removed, leaving the self-assembled ECM available for later autologous cell repopulation and in situ basement membrane formation. One must note that a single population of newborn cells, vetted for adventitious infectious agents, was used for the matrix bank production. This minimises the risks of infectious disease transmission from grafts composed from multiple donors, as seen with acellular human cadaver skin. Many different protocols for dermis decellularization have been proposed to generate such matrices using various chemical, enzymatic and physical agents. 17 Aggressive decellularization processes can be more effective for removing cell residues, but are also generally more disruptive for the ECM elements. 17, 18 In order to preserve the extracellular matrix integrity as much as possible following the decellularization process, a minimally disruptive decellularization technique without any chemical or enzymes was used to produce the acellular dermal matrices. Moreover, the long-term preservation of acellular dermal matrices allows the generation of readily available scaffolds which can be used at a later appropriate time.
This study describes a method that reduced the production time for autologous bilayered SASS up to at least 3 weeks by using a decellularized self-assembled dermal matrix. Our results demonstrated a significant reduction in production time from patient biopsy to clinical availability as well as the generation of a skin substitute that presented This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
Materials and Methods
Cell culture
Neonatal fibroblasts and keratinocytes were extracted from a single donor (4-days-old)
foreskin biopsy by the two-step thermolysin and trypsin isolation procedure, as previously described. 12, 19 Briefly, the epidermis and dermis were gently separated after a thermolysin incubation step using fine forceps (0.5 mg/mL, Sigma, St-Louis, MO, USA).
Fibroblasts were isolated from the dermis using collagenase H (Roche Diagnostics, Laval, Qc, Canada) while keratinocytes were extracted from the epidermis using a trypsin/EDTA solution (0.05% trypsin (Intergen Company, Purchase, NY,USA), 0.01% EDTA/disodium salt (J.T Baker, Phillipsburg, NT, USA). Cells were then collected by centrifugation and inoculated into culture flasks.
Keratinocytes were grown on a feeder layer of irradiated human fibroblasts in This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. and antibiotics (penicillin 100 UI/ml, gentamicin 25 μg/ml). Both cell types were maintained at 37°C in a humidified incubator containing 8% CO 2 and culture media were changed three times per week during the culture period.
Production of self-assembled skin substitutes (SASS)
Standard SASS were obtained using the self-assembly reconstruction method, as previously described. 7, 12 Briefly, fibroblasts were first expanded for 7 days in DMEM 10% FCS. After expansion (7 days), fibroblasts were seeded in flasks (Falcon) at 4 X 10 3 cells/cm 2 and cultured for 25 days in DMEM 10% FCS 50 µg/ml ascorbic acid.
Fibroblasts secreted their own extracellular matrix (ECM) and produced cohesive sheets.
These sheets were then stacked to form a dermal substitute composed of fibroblasts and their ECM. These dermal substitutes were cultured one week to allow for sheets fusion.
Keratinocytes were then seeded on the dermal substitutes at 1 X 10 5 /cm 2 in order to form the epidermal layer. Keratinocyte proliferation onto the dermal substitute was allowed by culturing immersed in medium for one week. Final keratinocytes differentiation took place after the skin substitute was raised at the air-liquid interface 20 for an additional 10 days. Thus the total production duration was 8 weeks (56 days). This duration is calculated from a starting point that occurs 9-10 days after cells have been harvested from a patient's biopsy and subjected to an initial culture (see Figure 1A ).
Production of a decellularized self-assembled dermal template (DM)
Neonatal fibroblasts were seeded at 4 X 10 3 cells/cm 2 in a 75 cm 2 flask (Falcon, BD, Franklin Lakes, NJ, USA) and cultured for 19 days in DMEM supplemented with 10% This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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FCS and containing 50 μg/ml ascorbic acid to produce tissue sheets. 12 Three dermal sheets were superimposed to form a tissue-engineered dermal template comprised of fibroblasts and their self-secreted extracellular matrix, and cultured for a week to allow an appropriate cohesion between the sheets. 7 Following this culture period, the dermal templates were decellularized using two cycles of osmotic shock, followed by a rinsing and a dehydration process. 21 The dermal templates were first immersed in hypo-osmolar sterile apyrogen water (Milli-Q, EMD Millipore, Bellerica, MA, USA) for five hours at 4°C. The dermal templates were then gently rinsed once using sterile apyrogen water.
Following supernatant aspiration, they were left overnight, dishes open, in an actively operating laminar flow cabinet. The next day, they were submitted to a second cycle of the previously described process to result in the decellularized DM. Finally, the DM were frozen at -20°C and stored until further usage.
Decellularized dermal matrix rehydration. Frozen DM were thawed overnight at 4°C in cold DMEM containing penicillin 100 UI/ml and gentamicin 25 μg/ml and 0.5 µg/ml amphotericin B. The next day, they were immersed in DMEM containing 10% FCS with penicillin 100 UI/ml and gentamicin 25 μg/ml and kept in an incubator for one day.
Rehydrated DM were then used for further SASS-DM reconstruction.
Production of bilayered self-assembled skin substitutes using decellularized dermal matrices (SASS-DM)
Fibroblasts were expanded in culture for a week in DMEM 10% FCS and then seeded at a 4.2 x 10 4 cells/cm 2 density on thawed matrices. The recellularized matrices were cultured in DMEM containing 10% FCS 50µg/ml ascorbic acid for a week to allow This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. Following that culture step, keratinocytes were seeded as described above for SASS production. The total production duration of SASS-DM was thus four and a half weeks (31 days). This duration is calculated from a starting point that occurs 9-10-days after cells have been harvested from a patient's biopsy and subjected to an initial culture, prior to the selected start point where they are seeded for a 7-day expansion time (see Figure   1B ). 
Histological and immunofluorescence analysis
Mechanical properties analysis
Uniaxial tensile tests were performed on tissue specimens prepared using a dog bone shaped die-cut and using a Trytron TM 250 MicroForce Testing System (MTS Systems Corporation, Eden Prairie, MN, USA) as previously described. 24 The skin specimens were placed between a static and a dynamic anchorage. The movement of the dynamic anchorage at a constant displacement rate of 0.2 mm per second pulled on the tissue until rupture, while a load cell recorded the load applied on the sample. The ultimate tensile strength (UTS) and failure strain were defined respectively by the peak stress (MPa) and maximum deformation (%) withstood by the samples prior to failure. The tensile modulus was defined as the slope of the linear portion of the stress-strain curve in the 25-80% range of the UTS of the sample, 24 thus producing information about tissue stiffness. The applied stresses and strains were calculated by dividing the recorded load level by the initial cross-sectional area of the sample using the width of the die-cut and the thickness of the sample based on histology. A minimum of 4 specimens were tested per condition and stress-strain curves were plotted and analyzed using a Matlab© script (The Mathworks, Natick, MA, USA). This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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The aim of the work described herein was to reduce the fabrication time required for the production of autologous SASS from patient biopsy to clinical availability. In the current study, the dermal culture phase was circumvented by the use of a self-assembled decellularized and dehydrated dermal matrix (DM) produced using non autologous cells and allowing the initiation of patient cell culture further along in the reconstruction process ( Figure 1 ). Thus, this strategy allowed the standard eight weeks SASS reconstruction protocol to be shortened to about four weeks and a half ( Figure 1A , B).
The obtained SASS-DM were resistant, could be handled easily and presented a macroscopically uniform stratum corneum as SASS ( within the engineered tissue ( Figure 4D ). The expression of those markers suggests adequate epidermal differentiation as well as stem cell preservation into the skin substitute.
The presence of type IV collagen and laminin, both essential components of the basement membrane structure, was evaluated since the basement membrane is very important for the cohesion at the dermo-epidermal junction. As expected, type IV collagen and laminin were expressed at the interface between the dermal template and the epithelium within the SASS-DM ( Figure 4 ). The presence of hemidesmosomes and a basement membrane in the SASS-DM was further confirmed by TEM ( Figure 5 ).
Immunofluorescence assays performed on the DM after decellularization showed expression of key native dermal constituents such as type I and type III collagens, decorin 26 and tenascin-C 27 ( Figure 6 ). The intensity of these markers was preserved once final SASS-DM reconstruction was achieved ( Figure 6 ). TEM analysis showed dense bundles of collagen, without disruption of the extracellular matrix microstructure following decellularization ( Figure 5 ). Fibroblasts were shown to be surrounded by a dense matrix found in both superficial and deeper portions of the SASS-DM dermal layer ( Figure 5 ).
Mechanical testing was conducted on the tissues to compare the resistance of SASS with SASS-DM ( Figure 7) . A characteristic viscoelastic stress-strain curve was obtained for every sample submitted to tensile testing, displaying a toe-region followed by a linear segment and a rupturing point (not shown), defining the ultimate tensile strength (UTS) and failure strain of the tissue. Results showed no significant differences between the This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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tested samples. Thus, the use of a decellularized DM in tissue-engineered skin reconstruction was not shown to interfere with its mechanical characteristics. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Discussion
In this study, we described the production of a bilayered skin substitute using a decellularized dermal matrix that allowed us to reduce the production time up to three and half weeks. In the standard protocol, the culture of fibroblast until the formation of a manipulable tissue sheet can take 21 to 28 days depending on the fibroblast capacity to secrete ECM, which is donor dependent. The new fabrication protocol presents significant clinical interest since it considerably reduces the culture period with patient cells required for autologous tissue production and results in skin substitutes with resistant dermal matrix from any patient, regardless of their fibroblasts' ability to synthesize ECM. The use of this previously prepared decellularized dermal matrix for skin tissue engineering allowed the bypassing of the longest phase of the SASS culture, the production of an adequate dermal component (Figure 1 ). Furthermore, this approach allowed the production of banks of standardized self-assembled dermal templates that can be frozen and used as clinical need arises.
A production timeframe of four weeks and a half is comparable to some currently available autologous skin substitutes. Tissue-Tech Autograft System™ is a skin substitute in which autologous fibroblasts and keratinocytes are seeded in a microperforated hyaluronic acid template and grafted onto patients in two steps. The dermal equivalent is first grafted after a week of cell culture, then the epidermal substitute is apposed on top of the dermal equivalent after another week of cell culture.
Thus, skin substitute is available in a minimum of 2 weeks and it requires 2 operations for the patient. Permaderm© is another bilayered autologous skin substitute in which fibroblasts are seeded into a dermal template composed of a polymer of bovine collagen This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. The DM substitute proposed herein is reconstructed from newborn allogeneic cells that will be destroyed by a decellularization process before DM is used for the production of autologous SASS. Newborn allogeneic cells have previously been used safely and This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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16 successfully in skin substitutes grafted as temporary coverage in the treatment of severely burned patients. 39 Neonatal allogeneic fibroblasts alone seeded in a bioabsorbable polyglactin mesh or on bovine collagen coated mesh, or neonatal allogeneic fibroblasts together with keratinocytes seeded in a bovine collagen scaffold 40, 41 resulted in no adverse reaction, [42] [43] [44] while final rejection of the grafts can be observed when living cells were grafted.
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In a clinical setting, these allografts are applied on burns to cover, prepare and stabilize extensive wounds before the definitive skin autograft. These temporary allografts are gradually rejected by the immune system, the initiation of rejection occuring at a mean of two weeks after grafting. 45 Once rejected, these grafts need to be removed and replaced until the final treatment is available. Thus, the reduction of the production time from eight to four weeks can be of critical benefit from a clinical standpoint since only one cycle of allograft or xenograft application may be necessary, instead of multiple courses, before the application of a product that offers a final treatment. This is expected to reduce the clinical morbidity of patients.
Conclusion
We described a novel production technique to accelerate the fabrication of bilayered self-assembled skin substitutes. The use of a pre-produced decellularized self-assembled dermal matrix allowed us to circumvent the time consuming dermal reconstruction phase of the standard tissue-engineered skin reconstruction protocol. This strategy allowed a reduction of three weeks and a half from the eight weeks standard production time required to produce the SASS. This should represent a significant clinical gain for burn This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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patient treatment. The SASS-DM showed structural features, cell differentiation behavior and mechanical properties similar to a standard bilayered SSAS. Thus, this model could be an important adjunct to current burn treatment options. In vivo grafting of these faster produced SASS is ongoing. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
